presentation: regulating the advertising of therapeutic goods...presentation to determine the...
TRANSCRIPT
Regulating the advertising of therapeutic goodsA legislative overview
Advertising Education and Assurance SectionRegulatory Compliance BranchRegulatory Practice and Support Division
CHP Australia -Therapeutic Goods Advertising Code SeminarMarch/April 2020
Before we begin…
You need to know that:• The information in this session is not
comprehensive• You should not rely on this
presentation to determine the compliance of your advertising
• The content is not binding on the TGA
We have assumed that:• You are familiar with the Poisons
Standard and scheduling of medicines• You know how to locate the
Therapeutic Goods Act and Advertising Code
• You have a basic level of knowledge about the Code
• You know the definitions for ‘therapeutic good’ and ‘therapeutic use’
1
Three levels of advertising controls
• Legislation administered by the TGARegulation
• Advertising pre-approvals (shared with industry)Co-regulation
• Industry CodesSelf-regulation2
Therapeutic goods advertising legislation•
–––
•
•
The advertising requirements are set out in the:
Therapeutic Goods ActTherapeutic Goods RegulationsTherapeutic Goods Advertising Code
Advertising is also subject to the Competition and Consumer Act (Australian Consumer Law)
Australian Health Practitioner Regulation Agency law may also apply
3
Therapeutic Goods Act 1989
4
Definition of ‘advertise’ – s.3 of the Act“... includes make any statement, pictorial representation or design that is intended, whether directly or indirectly, to promote the use or supply of the goods, including where the statement, pictorial representation or design:(a) is on the label of the goods; or(b) is on the package in which the goods are contained; or(c) is on any material included with the package in which the goods are contained.”
Very broad definitionCaptures advertising irrespective of the medium (e.g. online, print, TV, radio)
5
The therapeutic goods advertising requirements•
––
•
–––
The advertising requirements are specified in the form of criminal offence and civil penalty provisions in the Act
Offences specific to particular types of therapeutic goodsGeneral advertising offences
The TGA doesn’t necessarily take court action against advertising that contravenes these offences – we may use other tools:
Administrative tools – cancellation/suspension from ARTGCompliance toolsEnforcement tools
6
Key advertising offence provisionsAudience Type of good Offence for Criminal offence Civil
penalty
Any
(including health profs)
Medicines, OTGs Promoting off-label use ss.22(2), (3) & (5) ss.21B(4)
Biologicals Promoting off-label use ss.32BJ(2A)-(4) s.32BL
Devices Promoting off-label use s.42ML s.41MLB
Consumers only
All Pre-approval offences s.42C N/A
All General advertising offences s.42DL s.42DLB
All Non-compliance with Code s.42DM s.42DMA7
Section 42DL – prohibits advertisements:••••
•
•
for prescription medicinesfor biologicalsfor illegal (unapproved) productswith prohibited representations that have not been permitted by the TGA with restricted representations that have not been permitted by the TGAwith government endorsement, references to the Act
The Act – general advertising offence
8
Rationale for the Advertising Code•
•
Therapeutic goods advertising legislation goes beyond the legal requirements for advertising ordinary consumer goods – because:
they are not ordinary goodsconsumers seeking a therapeutic good may be vulnerable due to a health condition or concerns about a possible health condition
The Code exists so that advertisements:are truthful and give consumers adequate information on risks and cautions to enable informed health choicespromote only the safe and proper use of therapeutic goodsis ethical and does not mislead or deceive the consumer or create unrealistic expectations about product performance
9
Therapeutic Goods Advertising Code •
––––
•––––
Advertising must:be accurate, balanced & verifiednot mislead nor arouse unwarranted expectationsnot lead to self diagnosis and/or inappropriate treatment must match the indications for the product
Other specific requirements include:must not advertise goods as ‘safe’, miraculousno endorsements by health professionals or governmentmust not imply that other goods are harmful or ineffectualcertain mandatory statements must be included
10
Prohibited and Restricted Representations
11
Prohibited representations••
:––––
••
Representations specified in (or through) the RegulationsAny representation regarding the treatment, cure, prevention, diagnosis (including screening), monitoring or susceptibility of, or pre-disposition to, the following diseases
Neoplastic diseasesSexually Transmitted Diseases (STD)HIV AIDS and/or Hepatitis C virusesMental illness
Abortifacient action claimsOther claims – including for antiseptics & disinfectants
Legislative definition: see s.42DJ of Act, read with Regulation 6B & Part 1 of Schedule 2 of the Regulations and s.30 of the Code
12
Restricted representations•
•
•
Restricted representations must be approved or permitted by the TGA before being used in an advertisement
A representation in advertising that refers, expressly or by implication, to a serious form of a disease, condition, ailment or defect, as defined in s.28 of the Code, needs prior approvalNote exclusions for uncomplicatedpregnancy and conditions that can be self-managed post-diagnosis
Legislative definition: see s.42DD of the Act, read with s.28 of the Code
13
Applying for approval to use a restricted representation•
‒‒
•
•
•
Legislative requirements for applications:Set out in sections 42DD to s.42DKIncludes the criteria TGA use to decide whether to approve an application
New online form contains checklists
Frame your application to address the criteria the TGA have to assessGuidance and approvals also available on website - www.tga.gov.au/form/application-approval-use-restricted-representation-advertising
14
Unapproved prohibited and restricted representations -possible consequences 2. Cease making claims or represtntations for Gumby Gumby capsules outright or in the form of testimonials that:
i. They have or may have an effect on cancer of any sort, location or grade;ii. They have or may have an effect on arthritis, chronic fatigue syndrome, or skin diseases.iii. The have or may have any other therapeutic use whatsoever while ever the capsules are not included in the Australia Register of Therapeutic Goods (ARTG);iv. You can or are able to arrance the supply of these therapeutic goods which are not included in the ARTG and not excluded or exempted from that requirement.
See - https://www.tga.gov.au/direction-about-advertisement-gumby-gumby-capsules
15
Interface issues: services, foods, cosmetics and
consumer goods
16
Interfaces with therapeutic goods regulation•
••••
•
The TGA does not ordinarily regulate the supply, provision or advertising of:Health servicesFoodsCosmeticsConsumer goods
The way these things are promoted could result in the advertising or products being captured under the therapeutic goods legislation
17
The definition of “therapeutic goods” EXCLUDES –••
‒‒
goods declared by the TGA to NOT be therapeutic goods; orfoods for which:
there is a prescribed standard in ANZ Food Standards Code, orthere is a tradition of use in ANZ as foods in the form in which they are presented
Interface Issues - overview
18
Interface issues: Foods
Foodor therapeutic
good?
19
Food - Medicine interface guidance tool
• Search “food medicine interface guidance tool” on TGA website
20
•
–
•‒
‒
Cosmetics are regulated under legislation administered by the National Industrial Chemicals Notification & Assessment Scheme:
the Industrial Chemical Notification Act 1990 (ICNA Act)
A cosmetic:must meet the definition of “cosmetic” in the ICNA Act
cannot be a ‘therapeutic good’ within the meaning of the Therapeutic Goods Act 1989
i.e. must not be for preventing, diagnosing, curing or alleviating a disease, ailment, defect or injury in persons
Interface issues - Cosmetics
21
Interface issues – Cosmetics
https://www.nicnas.gov.au/cosmetics-and-soaps/is-my-product-a-cosmetic 22
Interface issues - Cosmetic products
23
Interface issues – Consumer products
24
Some top tips… Check if your advertisements need approvals
Ensure claims are consistent with indications/intended purpose in ARTG
Before advertising – is it a therapeutic good…or something else?
Don’t advertise with prohibited or unapproved restricted representations
25
TGA’s advertising complaints handling: framework and insights
Our approach to handling complaints•
•––
–
–
Our approach is published on the TGA website: https://www.tga.gov.au/publication/complaints-handling-advertising-therapeutic-goods-australian-public
Some key principles:We focus resources on alleged non-compliance with highest public safety risksWe consider the perceptions of & impact on ‘reasonable consumer’ when assessing advertisingCompliance/enforcement actions are evidence-based and depend on the types of behaviours identified, including willingness of advertiser to be compliantOur processes support consistent compliance and enforcement outcomes and provide clarity for the public and advertisers
27
What’s in our compliance toolkit?Voluntary compliance•••
•
•
Education program (further information about this later in the afternoon)Enquiry servicesAdvertising pre-approvals remain until June 2020
Assisted complianceObligations Notice – informs advertisers their advertising may not be compliant and advises them of their obligationsWarning - informs advertisers their advertising is non-compliant and advises them of regulatory action that may be taken if they fail to respond/comply – requires a written response
28
What’s in our compliance toolkit? (2)Regulatory Compliance•••••••••
Substantiation NoticeDirections NoticeCancellation or suspension of the therapeutic good from the ARTGPublic Warning NoticeInjunction from the Federal Court or Federal Circuit CourtInfringement NoticeEnforceable Undertaking Prosecution of a civil penalty provisionReferral to the Commonwealth Director of Public Prosecutions for criminal prosecution
29
Trends in compliance•
–
–
––
•
For the period 1 October 2019 – 31 December 201987% of the 358 complaints received were about advertising in social media and web-based platforms1,233 products featured in advertising complaints in this period – medicines (40%), medical devices (15%) and not on the ARTG (45%)79% of all cases were categorised as ‘low’; the remainder were ‘medium’ and ‘high’Of the ‘medium’ cases the following themes were identified:
Weight loss products, hangover products, memory enhancement (Ginkgo biloba), Benign prostatic hypertrophy (Saw Palmetto), muscle cramps (magnesium), heart health (CoQ10) and pain relief devices.
Coronavirus is an emerging issue – note published web statement
30
Top tips to prevent compliance action Be contactable by the TGA
If you receive correspondence from the TGA, read it
Reply to TGA correspondence within specified timeframe
Have robust procedures in your business for dealing with correspondence and checking advertising compliance
Address compliance issues expeditiously
Don’t wait for a complaint to collate supporting evidence for ads
31
The benefits of compliant advertising••••••
A robust and effective system of advertising controls Promotes responsible advertisingReinforces quality use of therapeutic goodsSupports consumer confidence and trustEnhances health outcomes for all AustraliansLevel playing field for business
32
Further informationWe provide tools to assist advertisers and in managing their compliance, including:•
–
–––
••
On the advertising hub: https://www.tga.gov.au/advertising-hubAustralian Regulatory Guidelines on Advertising Therapeutic GoodsCode guidanceFact sheets and decision treesPresentations from seminars
Facebook, Twitter, InstagramAdvertising mailing list
• Contact: [email protected]
33